Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-based Assessment of Cerebral Small Vessel Disease Progression After Lacunar and Territorial Stroke - a Prospective Cohort Study

NCT07611136 is registered in ClinicalTrials.gov with Johannes Dorst as lead sponsor.

NCT NCT07611136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07611136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-based Assessment of Cerebral Small Vessel Disease Progression After Lacunar and Territorial Stroke - a Prospective Cohort Study
Lead sponsor
Johannes Dorst
Phase
Observational
Overall status
Recruiting
Start date
March 26, 2026
Completion date
April 1, 2028
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, cerebral small vessel disease, stroke, stroke recurrence